StockData
UNITED THERAPEUTICS Corp logo

UNITED THERAPEUTICS Corp (UTHR) stock

UTHRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 11/3022% above fair value
$584.10−3.78 (-0.64%)

Close on Nov 17, 2026Market cap $25.05BP/E 20.9Yield –

United Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

United Therapeutics's price to book ratio was 4.0× on Nov 11, 2026, against 3.2× a year earlier. Over the last 5 years it ranged from 1.8× to 4.0×, with a median of 2.5×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20264.0×+0.8
2025Dec 31, 20253.2×+0.6
2024Dec 31, 20242.6×+0.8
2023Dec 29, 20231.8×−1.0
2022Dec 30, 20222.8×+0.2
2021Dec 31, 20212.5×+0.5
2020Dec 31, 20202.1×+0.6
2019Dec 31, 20191.4×−0.3
2018Dec 31, 20181.8×−1.3
2017Dec 29, 20173.1×−0.2
2016Dec 30, 20163.3×−1.5
2015Dec 31, 20154.9×−0.3
2014Dec 31, 20145.2×+0.7
2013Dec 31, 20134.5×+1.9
2012Dec 31, 20122.6×+0.0
2011Dec 30, 20112.5×−1.5
2010Jul 30, 20104.1×−0.3
2009Dec 31, 20094.3×–

More United Therapeutics figures

See a number that looks wrong?